» Articles » PMID: 35745516

SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations

Abstract

Populations of RNA viruses are composed of complex and dynamic mixtures of variant genomes that are termed mutant spectra or mutant clouds. This applies also to SARS-CoV-2, and mutations that are detected at low frequency in an infected individual can be dominant (represented in the consensus sequence) in subsequent variants of interest or variants of concern. Here we briefly review the main conclusions of our work on mutant spectrum characterization of hepatitis C virus (HCV) and SARS-CoV-2 at the nucleotide and amino acid levels and address the following two new questions derived from previous results: (i) how is the SARS-CoV-2 mutant and deletion spectrum composition in diagnostic samples, when examined at progressively lower cut-off mutant frequency values in ultra-deep sequencing; (ii) how the frequency distribution of minority amino acid substitutions in SARS-CoV-2 compares with that of HCV sampled also from infected patients. The main conclusions are the following: (i) the number of different mutations found at low frequency in SARS-CoV-2 mutant spectra increases dramatically (50- to 100-fold) as the cut-off frequency for mutation detection is lowered from 0.5% to 0.1%, and (ii) that, contrary to HCV, SARS-CoV-2 mutant spectra exhibit a deficit of intermediate frequency amino acid substitutions. The possible origin and implications of mutant spectrum differences among RNA viruses are discussed.

Citing Articles

A general and biomedical perspective of viral quasispecies.

Domingo E, Martinez-Gonzalez B, Somovilla P, Garcia-Crespo C, Soria M, de Avila A RNA. 2024; 31(3):429-443.

PMID: 39689947 PMC: 11874995. DOI: 10.1261/rna.080280.124.


Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2.

Ferrer-Orta C, Vazquez-Monteagudo S, Ferrero D, Martinez-Gonzalez B, Perales C, Domingo E Proc Natl Acad Sci U S A. 2024; 121(29):e2317977121.

PMID: 38990941 PMC: 11260105. DOI: 10.1073/pnas.2317977121.


SARS-CoV-2 mutant spectra as variant of concern nurseries: endless variation?.

Martinez-Gonzalez B, Soria M, Minguez P, Lorenzo-Redondo R, Salar-Vidal L, Lopez-Garcia A Front Microbiol. 2024; 15:1358258.

PMID: 38559344 PMC: 10979541. DOI: 10.3389/fmicb.2024.1358258.


Editorial for the Topical Collection "SARS-CoV-2 Infection and COVID-19 Disease".

Martinez-Sobrido L, DeDiego M Pathogens. 2024; 13(3).

PMID: 38535534 PMC: 10976236. DOI: 10.3390/pathogens13030191.


Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.

Delgado S, Somovilla P, Ferrer-Orta C, Martinez-Gonzalez B, Vazquez-Monteagudo S, Munoz-Flores J Proc Natl Acad Sci U S A. 2024; 121(10):e2317851121.

PMID: 38416684 PMC: 10927536. DOI: 10.1073/pnas.2317851121.


References
1.
Quer J, Gregori J, Rodriguez-Frias F, Buti M, Madejon A, Perez-Del-Pulgar S . High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J Clin Microbiol. 2014; 53(1):219-26. PMC: 4290919. DOI: 10.1128/JCM.02093-14. View

2.
Andino R, Domingo E . Viral quasispecies. Virology. 2015; 479-480:46-51. PMC: 4826558. DOI: 10.1016/j.virol.2015.03.022. View

3.
Xue K, Hooper K, Ollodart A, Dingens A, Bloom J . Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture. Elife. 2016; 5:e13974. PMC: 4805539. DOI: 10.7554/eLife.13974. View

4.
Di Maio V, Cento V, Lenci I, Aragri M, Rossi P, Barbaliscia S . Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies. Liver Int. 2017; 37(4):514-528. DOI: 10.1111/liv.13327. View

5.
Sullivan J, De Meyer S, Bartels D, Dierynck I, Zhang E, Spanks J . Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials. Clin Infect Dis. 2013; 57(2):221-9. DOI: 10.1093/cid/cit226. View